However, the combined analysis of three AKT1SNPs identified that individuals carrying only one of three AKT1 variant genotypes might have decreased risk to develop ESCC cancer in comparison with non‐carriers, but this finding could be because of chance. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.